MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia

Leukemia Research

Volumn 37, Issue 6, 2013, Pages 647-656

  Coskun, Ebru ^a   Neumann, Martin ^a   Schlee, Cornelia ^a   Liebertz, Frauke ^a   Heesch, Sandra ^a   Goekbuget, Nicola ^b   Hoelzer, Dieter ^b   Baldus, Claudia D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

ETP ALL; Microrna; Microrna expression profiling; MiR 222; T ALL

Indexed keywords

MICRORNA; MICRORNA 151 3P; MICRORNA 19A; MICRORNA 20B; MICRORNA 221; MICRORNA 222; MICRORNA 342 3P; MICRORNA 363; MICRORNA 576 3P; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EARLY T CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COHORT STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JURKAT CELLS; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; PRECURSOR CELLS, T-LYMPHOID; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

EID: 84877048860     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.02.019     Document Type: Article

References (52)

1. Coustan-Smith E., Mullighan C.G., Onciu M., Behm F.G., Raimondi S.C., Pei D., et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009, 10:147-156.
2. Neumann M., Heesch S., Gökbuget N., Schwartz S., Schlee C., Benlasfer O., et al. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J 2012, 2:e55.
3. Felicetti F., Errico M.C., Bottero L., Segnalini P., Stoppacciaro A., Biffoni M., et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008, 68:2745-2754.
4. Wong Q.W., Ching A.K., Chan A.W., Choy K.W., To K.F., Lai P.B., et al. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res 2010, 16:867-875.
5. Song B., Wang Y., Kudo K., Gavin E.J., Xi Y., Ju J. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 2008, 14:8080-8086.
6. Su H., Yang J.-R., Xu T., Huang J., Xu L., Yuan Y., et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009, 69:1135-1142.
7. Naguibneva I., Ameyar-Zazoua M., Polesskaya A., Ait-Si-Ali S., Groisman R., Souidi M., et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 2006, 8:278-284.
8. Romania P., Lulli V., Pelosi E., Biffoni M., Peschle C., Marziali G. MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol 2008, 143:570-580.
9. Kosaka N., Sugiura K., Yamamoto Y., Yoshioka Y., Miyazaki H., Komatsu N., et al. Identification of erythropoietin-induced microRNAs in haematopoietic cells during erythroid differentiation. Br J Haematol 2008, 142:293-300.
10. Lawrie C.H. MicroRNAs and haematology: small molecules, big function. Br J Haematol 2007, 137:503-512.
11. Garzon R., Heaphy C.E., Havelange V., Fabbri M., Volinia S., Tsao T., et al. MicroRNA 29b functions in acute myeloid leukemia. Blood 2009, 114:5331-5341.
12. Bousquet M., Harris M. MicroRNA miR-125b causes leukemia. PNAS 2010, 107:21558-21563.
13. Gefen N., Binder V., Zaliova M., Linka Y., Morrow M., Novosel A., et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 2010, 24:89-96.
14. Bousquet M., Quelen C., Rosati R., Mansat-De Mas V., La Starza R., Bastard C., et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008, 205:2499-2506.
15. Klusmann J.-H., Li Z., Böhmer K., Maroz A., Koch M.L., Emmrich S., et al. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 2010, 24:478-490.
16. Marcucci G., Radmacher M.D., Maharry K., Mrózek K., Ruppert A.S., Paschka P., et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008, 358:1919-1928.
17. Marcucci G., Maharry K., Radmacher M.D., Mrózek K., Vukosavljevic T., Paschka P., et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 2008, 26:5078-5087.
18. Schotte D., De Menezes R.X., Moqadam F.A., Khankahdani L.M., Lange-Turenhout E., Chen C., et al. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica 2011, 96:703-711.
19. Fulci V., Colombo T., Chiaretti S., Messina M., Citarella F., Tavolaro S., et al. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes Cancer 2009, 48:1069-1082.
20. Mavrakis K.J., Van Der Meulen J., Wolfe A.L., Liu X., Mets E., Taghon T., et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet 2011, 43:673-678.
21. Baldus C.D., Burmeister T., Martus P., Schwartz S., Gökbuget N., Bloomfield C.D., et al. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. J Clin Oncol 2006, 24:4714-4720.
22. Kühnl A., Kaiser M., Neumann M., Fransecky L., Heesch S., Radmacher M., et al. High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia. Leukemia Res 2011, 35:1585-1590.
23. Haferlach T., Kohlmann A., Wieczorek L., Basso G., Kronnie G.T., Béné M.-C., et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 2010, 28:2529-2537.
24. Heesch S., Schlee C., Neumann M., Stroux A., Kühnl A., Schwartz S., et al. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia. Leukemia 2010, 24:1429-1436.
25. Heesch S., Goekbuget N., Stroux A., Tanchez J.O., Schlee C., Burmeister T., et al. Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia. Haematologica 2010, 95:942-949.
26. Mavrakis K.J., Wolfe A.L., Oricchio E., Palomero T., de Keersmaecker K., McJunkin K., et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 2010, 12:372-379.
27. Mi S., Lu J., Sun M., Li Z., Zhang H., Neilly M.B., et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. PNAS 2007, 104:19971-19976.
28. Landais S., Landry S., Legault P., Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007, 67:5699-5707.
29. Terasawa K., Ichimura A., Sato F., Shimizu K., Tsujimoto G. Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. FEBS J 2009, 276:3269-3276.
30. Mattia G., Errico M.C., Felicetti F., Petrini M., Bottero L., Tomasello L., et al. Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma. Pigment Cell Melanoma Res 2011, 24:953-965.
31. Zhu N., Zhang D., Chen S., Liu X., Lin L., Huang X., et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Arteriosclerosis 2011, 215:286-293.
32. Lulli V., Romania P., Riccioni R., Boe A., Lo-Coco F., Testa U., et al. Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation. Haematologica 2010, 95:1633-1641.
33. Opavsky R., Tsai S.-Y., Guimond M., Arora A., Opavska J., Becknell B., et al. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. PNAS 2007, 104:15400-15405.
34. Liu X., Cheng Y., Yang J., Xu L., Zhang C. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol 2012, 52:245-255.
35. Bell J.J., Bhandoola A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 2008, 452:764-767.
36. Zhang J., Ding L., Holmfeldt L., Wu G., Heatley S.L., Payne-Turner D., et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012, 481:157-163.
37. Wong P., Iwasaki M., Somervaille T.C.P., Ficara F., Carico C., Arnold C., et al. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Res 2010, 70:3833-3842.
38. Li Z., Lu J., Sun M., Mi S., Zhang H., Luo R.T., et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. PNAS 2008, 105:15535-15540.
39. Popovic R., Riesbeck L.E., Velu C.S., Chaubey A., Zhang J., Achille N.J., et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 2009, 113:3314-3322.
40. Neilson J.R., Zheng G.X.Y., Burge C.B., Sharp P. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 2007, 21:578-589.
41. Felli N., Fontana L., Pelosi E., Botta R., Bonci D., Facchiano F., et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. PNAS 2005, 102:18081-18086.
42. Chiaretti S., Messina M., Tavolaro S., Zardo G., Elia L., Vitale A., et al. Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223. Haematologica 2010, 95:1114-1121.
43. Bories J., Willerford D., Grèvin D., Davidson L., Camus A., Martin P., et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 1995, 377:635-638.
44. Muthusamy N., Barton K., Leiden J. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 1995, 377:639-642.
45. Koskela K., Lassila O. Single-cell analysis of Ets-1 transcription factor expression during lymphocyte activation and apoptosis. Scand J Immunol 2003, 57:56-61.
46. Yang C.-J., Shen W.G., Liu C.-J., Chen Y.-W., Lu H.-H., Tsai M.-M., et al. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. J Oral Pathol Med 2011, 40:560-566.
47. Fornari F., Gramantieri L., Ferracin M., Veronese A., Sabbioni S., Calin G.A., et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008, 27:5651-5661.
48. le Sage C., Nagel R., Egan D., Schrier M., Mesman E., Mangiola A., et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 2007, 26:3699-3708.
49. Zhang C.-Z., Zhang J.-X., Zhang A.-L., Shi Z.-D., Han L., Jia Z.-F., et al. MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 2010, 9:229.
50. Forrest A.R.R., Kanamori-Katayama M., Tomaru Y., Lassmann T., Ninomiya N., Takahashi Y., et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 2009, 24:460-466.
51. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284.
52. Ye H., Liu X., Lv M., Wu Y., Kuang S., Gong J., et al. MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia. Nucleic Acids Res 2012, 40:5201-5214. 10.1093/nar/gks175.